{"name":"Nutshell Therapeutics (Shanghai) Co., LTD.","slug":"nutshell-therapeutics-shanghai-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxQUHJ2elFHQmw3d0FfNnM2LUNIQkhyQk9OVDAtR056WnhGVlNidEs2OUJ1dEM5QTd6cmNIWXJJb2hPTGRZVDhjSUFtemFtTndZUDRNSUY5TUUxV01mTzdEZTJzbWJYODFhYURRNjRIM3p1VW0yVXBHSHdkb2EwWllZRFdrQU1CWkRiakNZZVRpOWN0cHpXeV9FZERyREtLUk5DQnpyTGpaQ2JLR3VxSVF6T1RqekJCN0lZV3d4UjZOR3Z5dEZlWlc0VFAxZVRSVUtlV016aU5URWdPWkU2YWE3R3oyUzAxd1NnSUk3Wng1MXVhV0xERFE?oc=5","date":"2025-05-04","type":"regulatory","source":"prnewswire.com","summary":"IND Application for NTS071, Nutshell Therapeutics' p53 Y220C Allosteric Reactivator, Received US FDA clearance - prnewswire.com","headline":"IND Application for NTS071, Nutshell Therapeutics' p53 Y220C Allosteric Reactivator, Received US FDA clearance","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}